Immunovant (IMVT) Property, Plant & Equipment (Net) (2019 - 2026)
Immunovant (IMVT) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 518.26 Mn |
| 10 | Immunovant | 7.32 Bn | 6.41 Bn | - | 443,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 443,000.00 |
| Mar 31, 2026 | 443,000.00 |
| Dec 31, 2025 | 531,000.00 |
| Dec 31, 2025 | 531,000.00 |
| Sep 30, 2025 | 632,000.00 |
| Sep 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Jun 30, 2025 | 737,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Dec 31, 2024 | 752,000.00 |
| Dec 31, 2024 | 752,000.00 |
| Sep 30, 2024 | 671,000.00 |
| Sep 30, 2024 | 671,000.00 |
| Jun 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 565,000.00 |
| Mar 31, 2024 | 462,000.00 |
| Mar 31, 2024 | 462,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Dec 31, 2023 | 376,000.00 |